Age
stringclasses 73
values | Date of Data Entry
stringlengths 4
19
| Gender
stringclasses 3
values | Diagnosis
stringlengths 3
81
| Name of Drug
stringclasses 57
values | Dosage (gram)
stringclasses 28
values | Route
stringclasses 4
values | Frequency
stringclasses 6
values | Duration (days)
stringclasses 15
values | Indication
stringlengths 1
53
⌀ |
|---|---|---|---|---|---|---|---|---|---|
41 | 19/12/2019 14:12:41 | Male | hepatic encephalopathy, col, hypokalaemia | ceftriaxone | 1 | IV | BD | 3 | hypokalaemia |
41 | 19/12/2019 14:13:29 | Male | hepatic encephalopathy, col, hypokalaemia | rifaximin | 0.55 | Oral | BD | 3 | hypokalaemia |
41 | 19/12/2019 14:13:55 | Male | hepatic encephalopathy, col, hypokalaemia | cefixime | 0.2 | Oral | BD | 3 | hypokalaemia |
54 | 19/12/2019 14:34:13 | Male | he, hypokalemia, ich | ceftriaxone | 2 | IV | BD | 2 | hypokalemia |
73 | 19/12/2019 14:41:27 | Female | svt, chest infection, old Koch'lung, hypokalemia | co-amoxiclav | 1.2 | IV | TDS | 4 | hypokalemia |
44 | 19/12/2019 15:18:24 | Female | ureteric stone, uti | ceftriaxone | 1 | IV | BD | 7 | i/t for generalized edema |
54 | 19/12/2019 14:34:13 | Male | he, hypokalemia, ich | ceftriaxone | 2 | IV | BD | 2 | ich |
85 | 19/12/2019 14:41:49 | Female | ccf, hypertension, ida, ckd(stage 5), ?icm, | ceftriaxone | 1 | IV | BD | 7 | icm |
85 | 19/12/2019 14:41:49 | Female | ccf, hypertension, ida, ckd(stage 5), ?icm, | ceftriaxone | 1 | IV | BD | 7 | ida |
85 | 19/12/2019 14:41:49 | Female | ccf, hypertension, ida, ckd(stage 5), ?icm, | ceftriaxone | 1 | IV | BD | 7 | ida |
64 | 19/12/2019 14:42:05 | Female | acute pulmonary edema, ihd, uti, type 2 dm, chest infection | gentamicin | 0.8 | IV | BD | 6 | ihd |
64 | 19/12/2019 14:42:34 | Female | acute pulmonary edema, ihd, uti, type 2 dm, chest infection | ceftriaxone | 1 | IV | BD | 5 | ihd |
67 | 19/12/2019 13:56:04 | Male | copd, cor pulmonale, ihd, koch’s lung | ceftazidime | 1 | IV | TDS | 5 | ihd |
60 | 19/12/2019 14:31:42 | Female | heart failure, hcv, col, ihd, ccf, chest infection | co-amoxiclav | 1.2 | IV | TDS | 1 | ihd |
60 | 19/12/2019 14:33:33 | Female | heart failure, hcv, col, ihd, ccf, chest infection | co-amoxiclav | 0.625 | Oral | OD | 5 | ihd |
68 | 19/12/2019 15:30:36 | Female | ihd | co-amoxiclav | 1.2 | IV | TDS | 4 | ihd |
68 | 19/12/2019 15:31:57 | Female | ihd | cefixime | 0.2 | Oral | BD | 1 | ihd |
78 | 19/12/2019 15:21:18 | Female | type 2 dm, hypoglycaemia, ihr | cefixime | 0.2 | Oral | BD | 5 | ihd |
74 | 19/12/2019 16:09:08 | Male | left sided hemiparesis, acute cerebral infarct, hypertension, ihd | ceftriaxone | 1 | IV | BD | 1 | ihd |
74 | 19/12/2019 16:11:35 | Male | left sided hemiparesis, acute cerebral infarct, hypertension, ihd | metronidazole | 0.75 | IV | TDS | 1 | ihd |
56 | 19/12/2019 14:44:46 | Male | uti, type 2 dm, ihd, hbs ag(+) | ceftriaxone | 1 | IV | BD | 1 | ihd |
56 | 19/12/2019 14:45:59 | Male | uti, type 2 dm, ihd, hbs ag(+) | levofloxacin | 0.2 | Oral | OD | 7 | ihd |
62 | 19/12/2019 14:06:07 | Female | ulcer at left leg, impaired glucose tolerance | cefixime | 0.2 | Oral | BD | 5 | impaired glucose tolerance |
62 | 19/12/2019 14:04:29 | Female | ulcer at left leg, impaired glucose tolerance | metronidazole | 0.75 | IV | TDS | 6 | impaired glucose tolerance |
62 | 19/12/2019 14:02:56 | Female | ulcer at left leg, impaired glucose tolerence | ceftazidime | 1 | IV | TDS | 6 | impaired glucose tolerence |
52 | 19/12/2019 14:37:18 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | septrin | 0.96 | Oral | OD | 1 | increased lft |
52 | 19/12/2019 14:38:22 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | coamoxiclav | 0.6 | IV | OD | 5 | increased lft |
52 | 19/12/2019 14:39:09 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | co-amoxiclav | 1.2 | IV | BD | 2 | increased lft |
82 | Time | Sex | Diagnosis | Drugs | Dosage | Route | Freq | Duration | Indication |
Age | #REF! | Sex | Diagnosis | Name of Drug | Dosage (gram) | Route | Frequency | Duration (days) | Indication |
19 | 19/12/2019 15:26:03 | Male | dka, otita media, cellulitis, type 2 dm | vancomycin | 1 | IV | BD | 10 | infection |
19 | 19/12/2019 15:26:54 | Male | dka, otita media, cellulitis, type 2 dm | levofloxacin | 0.5 | IV | BD | 11 | infection |
19 | 19/12/2019 15:27:56 | Male | dka, otita media, cellulitis, type 2 dm | clindamycin | 0.3 | IV | TDS | 10 | infection |
19 | 19/12/2019 15:29:05 | Male | dka, otita media, cellulitis, type 2 dm | metronidazole | 0.75 | IV | TDS | 8 | infection |
19 | 19/12/2019 15:29:48 | Male | dka, otita media, cellulitis, type 2 dm | cefepime | 1 | IV | TDS | 2 | infection |
50 | 19/12/2019 14:57:21 | Male | intracerebral haemorrhage | metronidazole | 0.75 | IV | TDS | 1 | intracerebral haemorrhage |
50 | 19/12/2019 14:57:53 | Male | intracerebral haemorrhage | ceftriaxone | 1 | IV | BD | 1 | intracerebral haemorrhage |
50 | 19/12/2019 16:27:17 | Male | thyrotoxicosis, joint pain, puo | ceftriaxone | 1 | IV | BD | 4 | joint pain |
78 | 19/12/2019 14:23:17 | Female | anteroseptal mi, klebsiella pneumonia, hypertension, type 2 dm, old stroke | co-amoxiclav | 1.2 | IV | TDS | 8 | klebsiella pneumonia |
45 | 19/12/2019 16:13:29 | Male | lung abscess, koch lung, chronic alcoholic | metronidazole | 0.75 | IV | TDS | 1 | koch's lung |
45 | 19/12/2019 16:15:02 | Male | lung abscess, koch lung, chronic alcoholic | ceftriaxone | 1 | IV | BD | 1 | koch's lung |
52 | 19/12/2019 16:22:38 | Female | upper gi bleeding d/t analgesis, art defaultes, rvi, chest infection, koch's lung | co-amoxiclav | 1.2 | IV | TDS | 6 | koch's lung |
40 | 19/12/2019 16:20:07 | Male | he, col, portal hypertension, hrs, koch's lung | ceftriaxone | 1 | IV | BD | 1 | koch's lung |
40 | 19/12/2019 16:21:01 | Male | he, col, portal hypertension, hrs, koch's lung | rifampicin | 0.55 | Oral | BD | 1 | koch's lung |
65 | 19/12/2019 14:49:08 | Male | koch's lung | co-amoxiclav | 0.625 | Oral | TDS | 5 | koch's lung |
42 | 19/12/2019 15:08:34 | Female | koch's lung, hbv infection | cefixime | 0.2 | Oral | BD | 5 | koch's lung |
52 | 19/12/2019 14:37:18 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | septrin | 0.96 | Oral | OD | 1 | koch's lung |
52 | 19/12/2019 14:38:22 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | coamoxiclav | 0.6 | IV | OD | 5 | koch's lung |
52 | 19/12/2019 14:39:09 | Female | rvi stage 3, ht disease, renal impairment, koch's lungs, ccf, increased lft | co-amoxiclav | 1.2 | IV | BD | 2 | koch's lung |
72 | 19/12/2019 14:37:41 | Female | copd ppt chest infection, old Koch,s lung | co-amoxiclav | 1.2 | IV | TDS | 1 | koch's lung |
57 | 19/12/2019 16:28:56 | Male | abscess on chin, uncontrolled type 2 dm, koch's lung | co-amoxiclav | 1.2 | IV | TDS | 4 | koch's lung |
57 | 19/12/2019 16:31:43 | Male | abscess on chin, uncontrolled type 2 dm, koch's lung | clindamycin | 0.2 | Oral | TDS | 7 | koch's lung |
72 | 19/12/2019 14:36:39 | Female | copd ppt chest infection, koch's lung | ceftriaxone | 1 | IV | TDS | 5 | koch's lung |
65 | 19/12/2019 16:22:50 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 1 | IV | TDS | 1 | koch's lung |
65 | 19/12/2019 16:24:34 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | co-amoxiclav | 0.625 | Oral | TDS | 2 | koch's lung |
65 | 19/12/2019 16:25:18 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | clarithromycin | 0.5 | Oral | BD | 4 | koch's lung |
65 | 19/12/2019 16:25:52 | Male | ccf, koch's lung, copd, chest infection, pre-diabetes | ceftriaxone | 1 | IV | BD | 2 | koch's lung |
53 | 19/12/2019 16:10:32 | Female | dm, acute ge, koch's lung | ceftriaxone | 1 | IV | BD | 3 | koch's lung |
53 | 19/12/2019 16:11:49 | Female | dm, acute ge, koch's lung | ciprofloxacin | 0.5 | Oral | BD | 2 | koch's lung |
67 | 19/12/2019 13:56:04 | Male | copd, cor pulmonale, ihd, koch’s lung | ceftazidime | 1 | IV | TDS | 5 | koch’s lung |
64 | 19/12/2019 14:24:06 | Male | hcv(+), col, koch’s lung | ceftriaxone | 1 | IV | BD | 1 | koch’s lung |
73 | 19/12/2019 14:41:27 | Female | svt, chest infection, old Koch'lung, hypokalemia | co-amoxiclav | 1.2 | IV | TDS | 4 | kochs'lung |
24 | 19/12/2019 14:20:23 | Male | left empyema , HCV infection | ceftiaxone | 1 | IV | BD | 1 | left empyema |
24 | 19/12/2019 14:21:41 | Male | left empyema , HCV infection | co-amoxiclav | 1.5 | IV | TDS | 1 | left empyema |
60 | 19/12/2019 15:46:26 | Male | left moderate pleural effusion | co-amoxiclav | 1.2 | IV | TDS | 5 | left moderate pleural effusion |
44 | 19/12/2019 15:25:01 | Male | alcohol hepatitis, left pleural effusion | cefexime | 0.5 | Oral | BD | 3 | left pleural effusion |
76 | 19/12/2019 14:59:02 | Female | acute pulmonary edema, left sided hemiparesis, aortic dissection | co-amoxiclav | 1.2 | IV | TDS | 1 | left sided hemiparesis |
76 | 19/12/2019 15:01:22 | Female | acute pulmonary edema, left sided hemiparesis, aortic dissection | metronidazole | 0.75 | IV | TDS | 1 | left sided hemiparesis |
74 | 19/12/2019 16:09:08 | Male | left sided hemiparesis, acute cerebral infarct, hypertension, ihd | ceftriaxone | 1 | IV | BD | 1 | left sided hemiparesis |
74 | 19/12/2019 16:11:35 | Male | left sided hemiparesis, acute cerebral infarct, hypertension, ihd | metronidazole | 0.75 | IV | TDS | 1 | left sided hemiparesis |
23 | 19/12/2019 14:28:41 | Female | left sided massive tuberculous pleural effusion | co-amoxiclav | 0.625 | Oral | TDS | 1 | left sided massive tuberculous pleural effusion |
46 | 19/12/2019 15:15:51 | Male | pleural effusion | co-amoxiclav | 0.625 | Oral | TDS | 5 | left sided pleural effusion |
17 | 19/12/2019 15:18:25 | Female | left sided tension pneumothorax | co-amoxiclav | 1.2 | IV | TDS | 7 | left sided tension pneumothorax |
40 | 19/12/2019 13:51:25 | Male | hepatitis, leptospirosis, typhoid | ceftriaxone | 1 | IV | BD | 1 | leptospirosis |
32 | 19/12/2019 15:30:42 | Male | prolonged fever ē, hypotension(leptospirosis) | ceftriaxone | 1 | IV | BD | 4 | leptospirosis |
48 | 19/12/2019 14:17:07 | Female | confusion, liver impairment,esophagocutaneous fistula | amoxicillin+flucloxacillin | 0.5 | Oral | TDS | 7 | liver impairment |
48 | 19/12/2019 14:18:00 | Female | confusion, liver impairment,esophagocutaneous fistula | streptomycin | 1 | IM | OD | 1 | liver impairment |
48 | 19/12/2019 14:18:35 | Female | confusion, liver impairment,esophagocutaneous fistula | levofloxacin | 0.75 | Oral | OD | 1 | liver impairment |
38 | 19/12/2019 15:26:31 | Male | alcohol withdrawal, extensive koch's lung, septic shock ē lrti | cefoparazone+sulbactam | 2 | IV | BD | 10 | lrti |
61 | 19/12/2019 15:37:15 | Male | ca lung, lung abscess | co-amoxiclav | 1.2 | IV | TDS | 3 | lung abscess |
61 | 19/12/2019 15:38:32 | Male | ca lung, lung abscess | co-amoxiclav | 0.625 | Oral | TDS | 3 | lung abscess |
45 | 19/12/2019 16:13:29 | Male | lung abscess, koch lung, chronic alcoholic | metronidazole | 0.75 | IV | TDS | 1 | lung abscess |
45 | 19/12/2019 16:15:02 | Male | lung abscess, koch lung, chronic alcoholic | ceftriaxone | 1 | IV | BD | 1 | lung abscess |
78 | 19/12/2019 14:13:33 | Male | lung condilation(rlz), CPOD | clarithromycin | 0.5 | Oral | BD | 10 | lung consodilation(rlz) |
78 | 19/12/2019 14:12:19 | Male | lung consodilation(rlz) , COPD | co-amoxiclav | 1.2 | IV | TDS | 1 | lung consodilation(rlz) |
25 | 19/12/2019 15:27:23 | Male | tuberculous lymphadenitis | ceftriaxone | 1 | IV | BD | 5 | lymphadenitis |
25 | 19/12/2019 15:28:44 | Male | tuberculous lymphadenitis | cefixime | 0.2 | Oral | BD | 5 | lymphadenitis |
13 | 19/12/2019 13:53:36 | Male | haematological, maglinancy | cefaziclime | 1 | IV | TDS | 5 | maglinancy |
13 | 19/12/2019 13:54:52 | Male | haematological, maglinancy | amikacin | 0.25 | IV | BD | 5 | maglinancy |
37 | 19/12/2019 16:31:43 | Male | massive ascites, col, portal hypertension | ceftriaxone | 1 | IV | BD | 4 | massive ascites |
37 | 19/12/2019 16:32:52 | Male | massive ascites, col, portal hypertension | septrin | 0.96 | Oral | OD | 1 | massive ascites |
28 | 19/12/2019 14:02:00 | Female | measle koch’s lung | cefixime | 0.2 | Oral | BD | 7 | measle koch’s lung |
23 | 19/12/2019 15:55:03 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | clindamycin | 150 | Oral | TDS | 5 | menilly sinusitis |
23 | 19/12/2019 15:50:16 | Male | discharge fits, dental caries, facial injury, menilly sinusitis | ceftriaxone | 1 | IV | BD | 1 | menilly sinusitis |
22 | 19/12/2019 16:06:58 | Male | meningoencephalitis | ceftriaxone | 1 | IV | BD | 3 | meningoencephalitis |
22 | 19/12/2019 16:05:33 | Male | meningoencephilitis | ceftriaxone | 2 | IV | BD | 1 | meningoencephilitis |
67 | 19/12/2019 14:39:41 | Female | uti , mi, dm, ckd, cuf, cff ppt by chest infection | ceftriaxone | 1 | IV | BD | 7 | mi |
48 | 19/12/2019 16:25:20 | Male | miliary tb, acute ge | metronidazole | 0.75 | IV | TDS | 1 | miliary tb |
48 | 19/12/2019 16:26:09 | Male | miliary tb, acute ge | ceftriaxone | 1 | IV | BD | 1 | miliary tb |
48 | 19/12/2019 16:27:49 | Male | miliary tb, acute ge | coamoxiclav | 0.625 | Oral | TDS | 5 | miliary tb |